Avita Medical, Inc. (RCEL) Financials
RCEL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 76.1 million | 42.6 million |
2023-09-30 | 52.1 million | 11.6 million |
2023-06-30 | 57.3 million | 11.7 million |
2023-03-31 | 62.2 million | 10.1 million |
RCEL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -7.6 million | 1.5 million |
2023-09-30 | -6.1 million | 1.6 million |
2023-06-30 | -6.2 million | 758300 |
2023-03-31 | -6.3 million | 1.8 million |
RCEL Net Income
No data available :(
RCEL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 1.8 million |
2023-09-30 | 38.6 million | - | 1.8 million |
2023-06-30 | 43.8 million | - | 694610 |
2023-03-31 | 49.3 million | - | 1.3 million |
RCEL Shares Outstanding
RCEL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 224829 | 4.6 million | 12.2 million | - |
2023-09-30 | 329111 | 2.8 million | 3.9 million | 6.8 million |
2023-06-30 | 201682 | 3.4 million | 4.1 million | 6.6 million |
2023-03-31 | 202008 | 3.1 million | 5.6 million | 4.4 million |
RCEL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 9.7 million | 1.2 million |
2023-09-30 | 8.8 million | 1.4 million |
2023-06-30 | 7.8 million | 1.5 million |
2023-03-31 | 7.1 million | 1.1 million |
RCEL
Price: $8.75
52 week price:
Earnings Per Share: -1.40 USD
P/E Ratio: -13.04
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 159000
Market Capitalization: 249.4 million